Using gastric cancer cells (AGS, MKN45, and SNU-1), we studied the molecular regulation of ILK and identified a non-canonical pathway of ILK-regulated ERK1/2 activation for NF-κB-mediated gastric cancer cell growth, migration, and survival promotion. This evidence concerns the gene MAPK3 and gastric cancer.